Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
Nucleoside (adenosine) analog; viral DNA polyme...
Triterpene found in species of Citrus; HIV-1 pr...
D2/3 agonist.
Xanthine oxidase inhibitor.
Nucleoside (deoxyguanosine) analog; DNA chain t...
Thienylbutyl ITC analog.
Endogenous neuropeptide hormone, lowers extrace...
CDK inhibitor.
Recombinant protein containing Treponema pallid...
Peptide; PAR1 agonist.
CDK4/6 inhibitor.
Alternaria mycotoxin which may be found in food...
Glucosinolate found in cruciferous vegetables.<...
Camptothecin derivative; topoisomerase I inhibi...
Peptide, involved in neutrophil activation; FPR...
PERK inhibitor.
Endogenous purine derivative of xanthine.
Pim-1 inhibitor.
NSAID; COX-1/2 and PDE inhibitor.
Catechol-type flavonoid; fatty acid synthesis i...